All news articles for November 2017

(Image: Getty/abluecup)

AAPS 2017

Align outsourcing strategies for success, say experts

By Melissa Fassbender

Pharmaceutical companies should share their outsourcing strategy across the company in order to ensure success, says panel discussing the benefits and challenges of working with contract organizations.

(Image: iStock/oatawa)

WCG acquires pharmacovigilance firm Vigilare

By Melissa Fassbender

WIRB Copernicus Group (WCG) has expanded its portfolio of companies to include the pharmacovigilance and drug safety solution provider Vigilare International.

(Image: iStock/kasto80)

ATCC adds novel in vitro model to expanding portfolio

By Melissa Fassbender

ATCC has released an in vitro model system for a key mechanism of invasion and metastasis in lung cancer as the company continues its efforts to provide drug discovery and development services.

GettyImages/utah778

AmerisourceBergen pays $815m for H.D. Smith

By Flora Southey

AmerisourceBergen Corporation will buy US wholesaler H.D. Smith, which it says will boost capabilities and help secure the pharmaceutical supply chain.

GettyImages/utah778

US FDA approves drug duo pill for HIV

By Flora Southey

The US Food and Drug Administration has approved ViiV Healthcare’s two-drug treatment for HIV-1 maintenance, the first time the drugs have been combined into a single pill.

(Image: iStock/AlexRaths)

Non-animal testing lab opens in China

By Melissa Fassbender

A Chinese regulatory institute has opened a non-animal testing laboratory – a model for regulatory bodies to show that implementing alternative methods into government laboratories is achievable, says IIVS president.

(Image: iStock/Ridofranz)

Avantor completes $6.5bn VWR acquisition

By Melissa Fassbender

Avantor, Inc. has completed its previously announced acquisition of VWR Corporation to create a global provider of “discovery-to-delivery” solutions, says CEO.

GettyImages/Feverpitched

UK drug development firm RxCelerate expands in US

By Flora Southey

Contract drug developer RxCelerate has opened an office in Massachusetts to expand its medicinal chemistry, antibody discovery, and preclinical safety services throughout North America.